nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—MPO—Carboplatin—ocular cancer	0.335	0.375	CbGbCtD
L-Carnitine—XDH—Carboplatin—ocular cancer	0.335	0.375	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—ocular cancer	0.223	0.25	CbGbCtD
L-Carnitine—CES1—Phase I biotransformations, non P450—ESD—ocular cancer	0.0428	0.399	CbGpPWpGaD
L-Carnitine—CPT2—PPAR Alpha Pathway—CDK4—ocular cancer	0.00274	0.0256	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDKN2C—ocular cancer	0.0027	0.0252	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—E2F5—ocular cancer	0.00225	0.021	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—E2F4—ocular cancer	0.0022	0.0205	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—MYBL2—ocular cancer	0.0022	0.0205	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—E2F2—ocular cancer	0.00216	0.0201	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—RBL1—ocular cancer	0.00216	0.0201	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—RBL2—ocular cancer	0.00198	0.0185	CbGpPWpGaD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CDK4—ocular cancer	0.0019	0.0177	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—E2F3—ocular cancer	0.00187	0.0175	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—RBBP4—ocular cancer	0.00187	0.0175	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDC25A—ocular cancer	0.00178	0.0166	CbGpPWpGaD
L-Carnitine—CPT2—PPAR Alpha Pathway—CCND1—ocular cancer	0.00177	0.0165	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—TFDP1—ocular cancer	0.00174	0.0162	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CCND3—ocular cancer	0.00158	0.0147	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—CRTC1—ocular cancer	0.00147	0.0137	CbGpPWpGaD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—ocular cancer	0.00142	0.0132	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—ID2—ocular cancer	0.00131	0.0122	CbGpPWpGaD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CCND1—ocular cancer	0.00123	0.0114	CbGpPWpGaD
L-Carnitine—CPT1A—RORA activates circadian gene expression—EP300—ocular cancer	0.00117	0.0109	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PSPH—ocular cancer	0.00107	0.00995	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—HDAC1—ocular cancer	0.00101	0.00943	CbGpPWpGaD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—ocular cancer	0.000985	0.00918	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CDK6—ocular cancer	0.000978	0.00911	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PSPH—ocular cancer	0.000908	0.00846	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PSPH—ocular cancer	0.000908	0.00846	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—E2F1—ocular cancer	0.000832	0.00776	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDK2—ocular cancer	0.000718	0.00669	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000676	0.0063	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—GNA11—ocular cancer	0.000659	0.00614	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian Clock—EP300—ocular cancer	0.000621	0.00578	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—GNAQ—ocular cancer	0.000612	0.00571	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—RB1—ocular cancer	0.00059	0.0055	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PSPH—ocular cancer	0.000585	0.00545	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—HDAC1—ocular cancer	0.000552	0.00514	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—ocular cancer	0.000545	0.00508	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—CDKN1A—ocular cancer	0.000544	0.00507	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000538	0.00501	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—EP300—ocular cancer	0.000514	0.00479	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000503	0.00469	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDKN1B—ocular cancer	0.000459	0.00428	CbGpPWpGaD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.000448	0.00418	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDKN1A—ocular cancer	0.000424	0.00395	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PSPH—ocular cancer	0.000405	0.00378	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—EP300—ocular cancer	0.000403	0.00376	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN1B—ocular cancer	0.000382	0.00356	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—ocular cancer	0.00037	0.00345	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—CDK4—ocular cancer	0.00037	0.00345	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—ocular cancer	0.000364	0.00339	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—EP300—ocular cancer	0.000356	0.00332	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN1A—ocular cancer	0.000352	0.00328	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—MYC—ocular cancer	0.000351	0.00327	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000349	0.00325	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000347	0.00323	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GNA11—ocular cancer	0.000336	0.00313	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—EP300—ocular cancer	0.000335	0.00312	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—ocular cancer	0.000313	0.00291	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GNAQ—ocular cancer	0.000312	0.00291	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—ocular cancer	0.000292	0.00272	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—ocular cancer	0.000291	0.00271	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GNA11—ocular cancer	0.000286	0.00266	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GNA11—ocular cancer	0.000286	0.00266	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00027	0.00251	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PSPH—ocular cancer	0.000269	0.0025	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GNAQ—ocular cancer	0.000266	0.00247	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GNAQ—ocular cancer	0.000266	0.00247	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000252	0.00235	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.00024	0.00224	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—ocular cancer	0.000229	0.00214	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—EP300—ocular cancer	0.00022	0.00205	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000214	0.002	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000214	0.002	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB1—ocular cancer	0.000201	0.00188	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GNA11—ocular cancer	0.000184	0.00172	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GNAQ—ocular cancer	0.000171	0.00159	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—ocular cancer	0.000157	0.00147	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PSPH—ocular cancer	0.000141	0.00132	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000138	0.00129	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNA11—ocular cancer	0.000128	0.00119	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNAQ—ocular cancer	0.000119	0.00111	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—EP300—ocular cancer	0.000112	0.00105	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.57e-05	0.000892	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—EP300—ocular cancer	9.54e-05	0.000889	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—EP300—ocular cancer	9.54e-05	0.000889	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNA11—ocular cancer	8.45e-05	0.000788	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNAQ—ocular cancer	7.86e-05	0.000732	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—ocular cancer	6.78e-05	0.000632	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—EP300—ocular cancer	6.15e-05	0.000573	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—ocular cancer	5.77e-05	0.000537	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—ocular cancer	5.77e-05	0.000537	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNA11—ocular cancer	4.45e-05	0.000414	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—EP300—ocular cancer	4.26e-05	0.000397	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNAQ—ocular cancer	4.14e-05	0.000385	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—ocular cancer	3.72e-05	0.000346	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.34e-05	0.000311	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—EP300—ocular cancer	2.82e-05	0.000263	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—ocular cancer	2.58e-05	0.00024	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—ocular cancer	1.71e-05	0.000159	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—EP300—ocular cancer	1.49e-05	0.000138	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—ocular cancer	8.98e-06	8.37e-05	CbGpPWpGaD
